前往化源商城

European Journal of Pharmacology 1999-07-01

Inhibition of cardiac inward-rectifier K+ current by terodiline.

SE Jones, Y Kasamaki, T Ogura, LM Shuba, JR McCullough, TF McDonald

文献索引:Eur. J. Pharmacol. 370(3) , 319-27, (1999)

全文:HTML全文

摘要

The antispasmodic agent terodiline has cardiotoxic effects that include QT lengthening. To determine whether inhibition of inwardly-rectifying K+ current (I(K1)) might be a factor in the cardiotoxicity, we measured I(K1) in guinea pig ventricular myocytes. Terodiline reduced outward I(K1) with an IC50 of 7 microM; maximal reduction was 60% with 100-300 microM concentration. Inhibition was independent of current direction, and persisted after removal of the drug. Terodiline (3-5 microM) lengthened action potentials in guinea pig papillary muscles by ca. 10%, primarily by slowing phase 3 repolarization; higher concentrations abbreviated the plateau and markedly slowed late repolarization. Terodiline washout provoked an extra lengthening, consistent with persistent inhibition of I(K1) and rapid recovery of net inward plateau current. The results suggest that inhibition of I(K1) is a likely factor in the cardiotoxicity of the drug.

相关化合物

结构式 名称/CAS号 全部文献
Terodiline hydrochloride 结构式 Terodiline hydrochloride
CAS:7082-21-5